See more : Sisram Medical Ltd (1696.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Ventas, Inc. (VTR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ventas, Inc., a leading company in the REIT – Healthcare Facilities industry within the Real Estate sector.
You may be interested
- Regency Silver Corp. (RSMXF) Income Statement Analysis – Financial Results
- Canature Health Technology Co., Ltd. (300272.SZ) Income Statement Analysis – Financial Results
- Tubacex, S.A. (0KD1.L) Income Statement Analysis – Financial Results
- Kaveri Seed Company Limited (KSCL.BO) Income Statement Analysis – Financial Results
- American Pacific Mining Corp. (USGD.CN) Income Statement Analysis – Financial Results
Ventas, Inc. (VTR)
About Ventas, Inc.
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries: healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.50B | 4.13B | 3.83B | 3.80B | 3.87B | 3.75B | 3.57B | 3.44B | 3.29B | 3.08B | 2.81B | 2.49B | 1.76B | 1.02B | 931.58M | 929.77M | 771.79M | 418.45M | 324.72M | 232.91M | 205.00M | 196.70M | 204.58M | 242.32M | 233.25M | 149.93M | 3.12B | 2.58B | 2.32B |
| Cost of Revenue | 3.73B | 2.28B | 2.09B | 1.94B | 1.81B | 1.69B | 1.49B | 1.44B | 1.41B | 1.21B | 1.12B | 979.23M | 678.64M | 325.47M | 302.81M | 306.94M | 198.13M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 770.72M | 1.85B | 1.74B | 1.86B | 2.06B | 2.05B | 2.09B | 2.00B | 1.88B | 1.86B | 1.69B | 1.51B | 1.09B | 691.40M | 628.76M | 622.82M | 573.67M | 418.45M | 324.72M | 232.91M | 205.00M | 196.70M | 204.58M | 242.32M | 233.25M | 149.93M | 3.12B | 2.58B | 2.32B |
| Gross Profit Ratio | 17.14% | 44.71% | 45.44% | 48.89% | 53.25% | 54.85% | 58.41% | 58.12% | 57.09% | 60.59% | 60.22% | 60.60% | 61.55% | 67.99% | 67.49% | 66.99% | 74.33% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | -0.01 | 0.02 | 0.09 | 0.10 | 0.10 | 0.36 | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 148.88M | 144.87M | 129.76M | 130.16M | 166.00M | 151.98M | 135.49M | 126.88M | 128.04M | 121.75M | 115.11M | 98.80M | 0.00 | 0.00 | 38.83M | 36.43M | 36.43M | 26.14M | 23.10M | 16.92M | 12.72M | 9.76M | 10.24M | 9.69M | 7.77M | 5.70M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.23M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 148.88M | 144.87M | 129.76M | 130.16M | 166.00M | 151.98M | 135.49M | 126.88M | 128.04M | 121.75M | 115.11M | 98.80M | 74.54M | 49.83M | 38.83M | 40.65M | 36.43M | 26.14M | 23.10M | 16.92M | 12.72M | 9.76M | 10.24M | 9.69M | 7.77M | 5.70M | 0.00 | 1.49B | 0.00 |
| Other Expenses | 0.00 | 1.22B | 1.19B | 1.13B | 1.05B | -66.77M | -20.05M | -9.99M | -17.96M | -38.93M | -18.73M | -6.96M | 0.00 | 0.00 | 263.98M | 161.70M | 161.70M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.94B | 1.36B | 1.32B | 1.26B | 1.21B | 1.07B | 1.02B | 1.03B | 1.02B | 948.66M | 837.07M | 824.78M | 365.13M | 265.22M | 244.49M | 274.35M | 246.12M | 154.55M | 100.61M | 68.50M | 66.64M | 69.49M | 63.27M | 64.03M | 100.66M | 37.97M | 2.79B | 2.53B | 2.32B |
| Cost & Expenses | 3.83B | 3.65B | 3.41B | 3.20B | 3.02B | 2.76B | 2.51B | 2.47B | 2.43B | 2.16B | 1.96B | 1.80B | 1.04B | 590.69M | 547.30M | 581.30M | 444.24M | 154.55M | 100.61M | 68.50M | 66.64M | 69.49M | 63.27M | 64.03M | 100.66M | 37.97M | 2.79B | 2.53B | 2.32B |
| Interest Income | 0.00 | 463.92M | 425.28M | 7.61M | 10.98M | 24.89M | 6.03M | 876.00K | 1.05M | 4.27M | 2.05M | 1.11M | 0.00 | 0.00 | 842.00K | 2.96M | 2.99M | 2.89M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 574.11M | 467.56M | 440.09M | 469.54M | 451.66M | 442.50M | 448.20M | 419.74M | 367.11M | 376.84M | 334.48M | 293.40M | 236.81M | 178.86M | 176.99M | 203.18M | 204.22M | 136.54M | 0.00 | 0.00 | 80.20M | 86.18M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.17B | 3.60B | 3.22B | 3.05B | 2.87B | 2.80B | 2.50B | 2.44B | 979.11M | 828.16M | 753.14M | 724.83M | 459.70M | 214.71M | 207.61M | 235.72M | 237.50M | 119.65M | 88.00M | 54.34M | 39.51M | 41.25M | 40.37M | 43.60M | 42.80M | 29.05M | 123.87M | 99.53M | 89.48M |
| EBITDA | 1.83B | 1.65B | 1.60B | 1.72B | 1.93B | 1.80B | 1.95B | 1.95B | 1.81B | 1.70B | 1.59B | 1.42B | 1.00B | 609.50M | 578.87M | 584.19M | 549.60M | 399.04M | 312.11M | 212.99M | 159.19M | 171.07M | 185.09M | 191.26M | 177.93M | 141.01M | 451.07M | 147.54M | 97.84M |
| EBITDA Ratio | 40.71% | 40.00% | 41.91% | 45.40% | 49.95% | 48.04% | 54.49% | 54.57% | 55.19% | 55.40% | 56.54% | 57.07% | 66.91% | 62.96% | 63.54% | 62.83% | 73.21% | 91.96% | 96.60% | 66.25% | 77.65% | 86.97% | 90.47% | 151.09% | 76.29% | 94.05% | 14.48% | 5.72% | 4.21% |
| Operating Income | 665.12M | 454.08M | 389.30M | 592.58M | 865.76M | 861.09M | 622.09M | 556.79M | 834.72M | 875.84M | 835.80M | 693.64M | 51.17M | 52.22M | 208.12M | 145.29M | 126.32M | 125.42M | 100.22M | 87.10M | 119.68M | 129.82M | 144.72M | 322.51M | 135.13M | 111.96M | 327.20M | 48.01M | 8.36M |
| Operating Income Ratio | 14.79% | 11.00% | 10.17% | 15.61% | 22.36% | 22.99% | 17.41% | 16.17% | 25.40% | 28.48% | 29.74% | 27.91% | 2.90% | 5.13% | 22.34% | 15.63% | 16.37% | 29.97% | 30.86% | 37.39% | 58.38% | 66.00% | 70.74% | 133.09% | 57.94% | 74.68% | 10.50% | 1.86% | 0.36% |
| Total Other Income/Expenses | -704.95M | -511.94M | -1.55B | -1.35B | -618.83M | -569.59M | -644.18M | -354.58M | -118.78M | -8.73M | -11.83M | -79.43M | -210.39M | -202.44M | -190.06M | -185.42M | -174.43M | -136.54M | -103.21M | -42.85M | -47.89M | -79.14M | -163.98M | -252.50M | -247.28M | -124.73M | -102.74M | 35.18M | 24.00M |
| Income Before Tax | -39.84M | -57.86M | 61.39M | 344.65M | 382.99M | 376.04M | 584.15M | 522.87M | 350.26M | 448.38M | 478.48M | 298.27M | 330.44M | 227.13M | 194.27M | 145.29M | 120.35M | 130.58M | 120.90M | 100.17M | 96.73M | 50.69M | 54.28M | -61.25M | 42.54M | 55.96M | 224.47M | 83.18M | 32.36M |
| Income Before Tax Ratio | -0.89% | -1.40% | 1.60% | 9.08% | 9.89% | 10.04% | 16.34% | 15.18% | 10.66% | 14.58% | 17.03% | 12.00% | 18.72% | 22.34% | 20.85% | 15.63% | 15.59% | 31.21% | 37.23% | 43.01% | 47.19% | 25.77% | 26.53% | -25.27% | 18.24% | 37.32% | 7.20% | 3.23% | 1.39% |
| Income Tax Expense | -9.54M | -16.93M | 4.83M | -96.53M | -56.31M | -39.95M | -59.80M | -31.34M | -39.28M | -8.73M | -11.83M | -6.28M | -31.14M | 5.20M | -1.72M | -15.89M | -28.04M | 132.47M | 93.53M | 43.52M | -22.91M | -2.20M | 2.69M | 243.75M | 91.30M | 21.15M | 89.34M | 35.18M | 24.00M |
| Net Income | -40.97M | -40.93M | 49.01M | 439.15M | 433.02M | 409.47M | 1.36B | 649.23M | 417.84M | 475.77M | 453.51M | 362.80M | 364.49M | 246.17M | 266.50M | 226.29M | 282.32M | 131.43M | 130.58M | 120.90M | 162.75M | 65.71M | 50.57M | -65.45M | 42.54M | 26.76M | 130.93M | 48.01M | -14.89M |
| Net Income Ratio | -0.91% | -0.99% | 1.28% | 11.57% | 11.18% | 10.93% | 37.95% | 18.85% | 12.71% | 15.47% | 16.14% | 14.60% | 20.65% | 24.21% | 28.61% | 24.34% | 36.58% | 31.41% | 40.21% | 51.91% | 79.39% | 33.40% | 24.72% | -27.01% | 18.24% | 17.85% | 4.20% | 1.86% | -0.64% |
| EPS | -0.10 | -0.11 | 0.13 | 1.18 | 1.18 | 1.15 | 3.82 | 1.88 | 1.26 | 1.62 | 1.55 | 1.24 | 1.60 | 1.57 | 1.75 | 1.62 | 2.26 | 1.26 | 1.37 | 1.45 | 2.05 | 0.95 | 0.74 | -0.96 | 0.63 | 0.39 | 1.90 | 0.68 | -0.24 |
| EPS Diluted | -0.10 | -0.11 | 0.13 | 1.17 | 1.17 | 1.14 | 3.78 | 1.86 | 1.25 | 1.60 | 1.54 | 1.23 | 1.58 | 1.56 | 1.74 | 1.62 | 2.25 | 1.25 | 1.36 | 1.43 | 2.03 | 0.93 | 0.73 | -0.96 | 0.63 | 0.39 | 1.86 | 0.68 | -0.21 |
| Weighted Avg Shares Out | 401.81M | 373.37M | 382.79M | 373.37M | 365.98M | 356.27M | 355.33M | 344.70M | 330.31M | 294.18M | 292.65M | 292.06M | 228.45M | 156.61M | 152.57M | 139.57M | 122.60M | 104.21M | 95.04M | 83.49M | 79.34M | 69.34M | 68.41M | 68.01M | 67.75M | 67.68M | 68.94M | 69.70M | 62.32M |
| Weighted Avg Shares Out (Dil) | 401.81M | 373.37M | 386.30M | 376.50M | 369.89M | 359.30M | 358.57M | 348.39M | 334.01M | 296.68M | 295.11M | 294.49M | 230.79M | 157.66M | 152.76M | 139.91M | 123.01M | 104.73M | 95.78M | 84.35M | 80.09M | 70.29M | 69.36M | 68.13M | 67.99M | 68.61M | 70.36M | 70.70M | 71.97M |
Ventas (VTR) Q2 FFO Beats Estimates on Higher Same-Store NOI
Ventas' (VTR) Q2 results reflect occupancy and revenue growth in its same-store senior housing operating portfolio.
Compared to Estimates, Ventas (VTR) Q2 Earnings: A Look at Key Metrics
The headline numbers for Ventas (VTR) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Healthcare REIT Ventas raises full-year FFO per share forecast
Ventas raised the lower end of its forecast for annual funds from operations on Thursday, banking on continued strength for its assisted living and senior housing properties to drive performance.
Ventas (VTR) Q2 FFO and Revenues Top Estimates
Ventas (VTR) came out with quarterly funds from operations (FFO) of $0.80 per share, beating the Zacks Consensus Estimate of $0.79 per share. This compares to FFO of $0.75 per share a year ago.
Ventas Reports 2024 Second Quarter Results
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today reported results for the second quarter ended June 30, 2024. CEO Remarks “We started 2024 with momentum, which continued in the second quarter as we delivered another quarter of strong...
Ventas (VTR) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Ventas (VTR), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2024.
What's in the Offing for Ventas (VTR) This Earnings Season?
Ventas' (VTR) Q2 earnings are likely to have benefitted from favorable SHOP operating trends, healthy demand for life-science real estate assets and accretive investments.
Time to Go: 3 Companies Who Should Ditch Their CEOs Immediately
On July 15, after two years in the top job, UK luxury brand Burberry Group (OTCMKTS: BURBY ) fired CEO Jonathan Akeroyd. While I doubt Akeroyd is a contender for the worst CEOs of all time list, his tenure there was much...
3 REITs to Buy for Retirement: July 2024
Real estate investment trusts (REITs) represent one of the best ways to get exposure to investing in real estate without having to take on the risks and capital expenditures of purchasing your own property. When buying into a REIT, investors...
Ventas Announces Second Quarter 2024 Earnings Release Date and Conference Call
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) will issue its second quarter 2024 earnings release after the close of trading on the New York Stock Exchange on Thursday, August 1, 2024. A conference call to discuss those earnings will be held on...
Source: https://incomestatements.info
Category: Stock Reports